Guru Ownership Trend
Guru Analysis for Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.74 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $783,636.43 net inflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Candel Therapeutics, Inc. (CADL)
Major holders include Steven Cohen ($1.33 M), Ken Fisher ($595,340), Cliff Asness ($210,296). According to the latest reported data, 3 tracked investment managers collectively hold approximately 207,400 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $783,636.43, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CADL. The total reported sell value was $62,622.
Yes, 1 managers opened new positions in CADL, and 2 increased their existing holdings. The total reported buy value was $846,258.43.